Accuray (ARAY) Gains from Investment Securities (2018 - 2026)
Accuray (ARAY) posted quarterly Gains from Investment Securities of -$3.4 million for Q1 2026, up 41.2% quarter-over-quarter from -$5.7 million in Q4 2025.
Accuray (ARAY) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Accuray's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities changed N/A year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at -$7.2 million (down 7757.45% YoY), while the FY2025 annual figure was $499000.0, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$3.4 million, up from -$5.7 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.9 million in Q3 2025, with the low at -$5.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Accuray | 35.97 Mn | -3.73 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.36 Mn |
| Mar 31, 2026 | -3.36 Mn |
| Dec 31, 2025 | -5.71 Mn |
| Dec 31, 2025 | -5.71 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2018 | 94,000.00 |
| Jun 30, 2018 | 94,000.00 |